Leadership Overview
Lupin has 10 executives leading key functions including strategy, finance, operations, and research.
Driven by a commitment to innovation, Lupin is dedicated to advancing global healthcare through imagination, compassion, and the relentless pursuit of a better tomorrow, building on a legacy of transformative growth.
Driven by a commitment to innovation, Lupin is dedicated to advancing global healthcare through imagination, compassion, and the relentless pursuit of a better tomorrow, building on a legacy of transformative growth.
Leadership Roles at Lupin
Ashutosh Inamdar - Chief Executive Officer
Ashutosh Inamdar, the Chief Executive Officer at Lupin, directs the overarching corporate strategy and global operations. This leadership position involves guiding the company's expansion into new markets and ensuring the successful execution of its long-term vision. Inamdar oversees the integration of various business units to foster synergy and drive sustainable growth across all divisions. The Chief Executive Officer's responsibilities include championing innovation and maintaining Lupin's commitment to improving patient lives worldwide. This role demands a deep understanding of the pharmaceutical landscape and a strategic approach to navigating complex global health challenges. Ashutosh Inamdar ensures that all strategic initiatives align with the company's core mission of delivering high-quality, affordable medicines.
Abdelaziz Toumi - Chief Executive Officer, Manufacturing Solutions
Abdelaziz Toumi, the Chief Executive Officer, Manufacturing Solutions at Lupin, leads the strategic direction and operational execution of Lupin's manufacturing capabilities. This executive oversees the development and implementation of advanced manufacturing processes and technologies across global facilities. Toumi's responsibilities include ensuring the highest standards of quality, safety, and compliance in all production activities. The Chief Executive Officer, Manufacturing Solutions drives initiatives to enhance operational efficiency, optimize resource utilization, and support the company's robust product pipeline. This critical role involves fostering innovation within manufacturing to maintain Lupin's competitive edge in the pharmaceutical industry. Abdelaziz Toumi ensures that manufacturing operations are agile, scalable, and aligned with the company's mission to provide accessible healthcare solutions worldwide.

Anil Kaushal - Chief Executive Officer, Lupinlife Consumer Healthcare Ltd (Subsidiary of Lupin)
Anil Kaushal, the Chief Executive Officer, Lupinlife Consumer Healthcare Ltd (Subsidiary of Lupin) at Lupin, spearheads the strategic growth and operational management of Lupin's consumer healthcare division. This executive directs the development and marketing of over-the-counter products designed to meet everyday health needs. Kaushal oversees market expansion initiatives, brand building, and product innovation within the consumer segment. The Chief Executive Officer, Lupinlife Consumer Healthcare Ltd (Subsidiary of Lupin) ensures that the subsidiary's operations are aligned with Lupin's broader mission of enhancing global well-being. This leadership role involves navigating the dynamic consumer healthcare market and identifying new opportunities for product development and market penetration. Anil Kaushal drives the success of Lupinlife by delivering accessible and trusted health solutions to consumers.
Satheesh Sekar - Chief of Staff To the Chief Executive Officer
Satheesh Sekar, the Chief of Staff To the Chief Executive Officer at Lupin, acts as a key strategic advisor and operational facilitator for the CEO. This role involves managing critical projects, coordinating cross-functional initiatives, and ensuring the efficient flow of information between the CEO and other executive leaders. Sekar supports the Chief Executive Officer in strategic planning, decision-making processes, and the execution of key corporate objectives. The Chief of Staff To the Chief Executive Officer's responsibilities include preparing reports, analyzing business performance, and facilitating communication across the organization. This position is essential for enhancing the CEO's effectiveness and driving strategic alignment throughout Lupin. Satheesh Sekar plays a vital role in translating the CEO's vision into actionable plans and ensuring their successful implementation.
Hitanshu Shah - Chief Financial Officer
Hitanshu Shah, the Chief Financial Officer at Lupin, manages all financial aspects of the global organization. This includes financial planning, risk management, and capital allocation to support strategic growth initiatives. Shah oversees the treasury functions, ensuring robust financial health and compliance with international accounting standards. The Chief Financial Officer's role is critical in driving profitability and optimizing financial performance across Lupin's diverse business segments. This leadership position involves close collaboration with other executives to secure funding for research and development and to evaluate potential mergers and acquisitions. Hitanshu Shah provides essential financial insights that inform corporate decision-making and ensure long-term fiscal stability for the company.
Sujal Thakkar - Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office
Sujal Thakkar, the Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office at Lupin, provides critical support in financial planning and strategic analysis. This role involves contributing to the development and execution of corporate financial strategies, including budgeting, forecasting, and investment analysis. Thakkar works closely with the Global Chief Financial Officer's office to ensure financial discipline and optimize resource allocation across the organization. The Deputy General Manager - Corporate Finance and Strategy. Executive Director and Global Chief Financial Officer Office's responsibilities include evaluating financial performance, identifying areas for cost optimization, and supporting strategic decision-making. This position is integral to maintaining Lupin's financial health and driving its long-term growth objectives. Sujal Thakkar ensures that financial operations are robust and aligned with the company's strategic vision.
Mudit Arora - Chief Operating Officer
Mudit Arora, the Chief Operating Officer at Lupin, directs the operational efficiency and effectiveness of the company's global manufacturing and supply chain networks. This role involves optimizing production processes, ensuring quality control, and managing logistics to meet market demands. Arora oversees the implementation of advanced manufacturing technologies to enhance productivity and reduce operational costs. The Chief Operating Officer's responsibilities extend to managing cross-functional teams to streamline workflows and improve overall business performance. This leadership position requires a keen focus on operational excellence and continuous improvement across all facets of production. Mudit Arora ensures that Lupin's operational capabilities consistently support the company's strategic objectives and its commitment to delivering essential medicines.
Rajeev Sibal - President, Business (India)
Rajeev Sibal, the President, Business (India) at Lupin, directs the strategic operations and commercial performance of Lupin's business within the Indian market. This executive is responsible for driving growth, expanding market share, and ensuring the successful launch and distribution of pharmaceutical products across India. Sibal oversees sales, marketing, and business development activities tailored to the specific needs and dynamics of the Indian healthcare landscape. The President, Business (India)'s role involves fostering strong relationships with healthcare professionals, regulatory bodies, and distribution partners. This leadership position is critical for solidifying Lupin's presence and impact in its home market. Rajeev Sibal ensures that Lupin's commitment to providing accessible and high-quality medicines is effectively realized throughout India.
Swati Kelkar - Research Scientist & Chief Revenue Officer
Swati Kelkar, the Research Scientist & Chief Revenue Officer at Lupin, bridges scientific innovation with commercial success. This dual role involves leading cutting-edge research initiatives while also driving revenue generation strategies across key markets. Kelkar oversees the translation of scientific discoveries into commercially viable products, ensuring alignment with market needs and regulatory requirements. The Research Scientist & Chief Revenue Officer's responsibilities include fostering a culture of innovation within the R&D departments and developing robust go-to-market plans. This leadership position is pivotal in maximizing the commercial potential of Lupin's product portfolio. Swati Kelkar ensures that scientific advancements directly contribute to the company's financial growth and its mission to improve global health outcomes.
Kiritkumar Dumraliya - Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office)
Kiritkumar Dumraliya, the Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office) at Lupin, leads the planning and execution of critical IT initiatives that support business objectives. This role involves overseeing the implementation of advanced technology solutions to enhance operational efficiency and drive digital transformation across the company. Dumraliya works closely with the Chief Information Officer's office to align IT projects with Lupin's strategic goals and ensure robust data security and system integrity. The Deputy General Manager - Strategic Information Technology Projects (Chief Information Officer Office)'s responsibilities include managing project timelines, budgets, and resources to deliver successful IT outcomes. This position is crucial for leveraging technology to foster innovation and maintain Lupin's competitive advantage. Kiritkumar Dumraliya ensures that IT infrastructure effectively supports the company's growth and operational needs.
Explore Leadership Teams in Manufacturing
Bliss GVS Pharma Limited is a global pharmaceutical company specializing in the manufacturing of a wide range of pharmaceutical products, including capsules, creams, injections, and various healthcare items. The company is recognized as the world's largest manufacturer of suppositories and pessaries, operating world-class facilities that prioritize quality and efficiency. Their mission focuses on discovering and rediscovering pharmaceutics to enhance well-being while increasing the accessibility of pharmaceuticals worldwide. The intended clients include healthcare providers and consumers seeking reliable and effective pharmaceutical solutions.
Company Leadership DS
VD
AM
SJ
Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally. The company operates in two segments, CDMO, and Biopharmaceutical Development and Commercialization. Its development services include discovery, cell line development, process development, and clinical manufacturing. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the research and commercialization of biosimilar drugs; development and manufacture of antibody-drug conjugates; and manufactures mammalian and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Company Leadership BB
TK
YK
Galderma is a global dermatology company focused exclusively on skin health, combining scientific innovation with consumer‑ and patient‑driven solutions. It develops and markets a comprehensive range of products and treatments across three main business areas injectable aesthetics, dermatological skincare, and therapeutic dermatology to address both cosmetic and medical skin conditions. Galderma partners closely with healthcare professionals worldwide to deliver science‑based care tailored to individual skin needs, from daily skincare and aesthetic treatments to prescription therapies. With a broad international presence and a heritage rooted in dermatological research, the company aims to advance skin health for people across different stages of life.
Company Leadership CK
BF
Revolution Medicines Inc is a pioneering biotechnology company committed to revolutionizing treatment for patients battling cancer. They are driven by a singular mission: the discovery, development, and delivery of innovative, targeted medicines, particularly focusing on what are known as RAS-addicted cancers, which represent a significant proportion of new human cancer diagnoses. The company has developed a groundbreaking tri-complex inhibitor platform to create a portfolio of RAS(ON) inhibitors, enabling a differentiated approach to target what was previously considered an undruggable molecular target in oncology. Through their tireless efforts and commitment to transformative science, they are building a deep pipeline of therapeutic candidates intended to change the standard of care for patients with these challenging diseases.
Company Leadership AS

SK